Trial intelligence / Profile preview

Tolvaptan in worsening heart failure (Secret of CHF)

NCT01584557Phase 3Completed

Sponsor
Cardiovascular Clinical Sciences
Start
Jun 2012
Primary completion
Jul 2016
Countries
1
01

Overview

A Phase 3 trial of tolvaptan in heart failure (HF), sponsored by Cardiovascular Clinical Sciences. Started Jun 2012; status: completed.

02

Drugs

tolvaptan
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01584557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01584557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call